Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial

Key facts

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Principal Investigator

Thurman Merritt

University of California, San Diego

Intervention

pulmonary surfactant(drug)

Eligibility

1 years · All sexes

Timeline

1986 – 1990

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Infant acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT07344714
  Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting
  Mayo Clinic
• RECRUITINGNCT07216053
  Predictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm Neonates
  Hackensack Meridian Health
• RECRUITINGNANCT03736707
  High-Frequency Oscillation Ventilation Versus Conventional Mechanical Ventilation in Very Preterm Infants With Perinatal Acute Respiratory Distress Syndrome: Multicenters Randomized Controlled, Superiority Trial
  Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
• RECRUITINGPHASE3NCT06776783
  Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
  Aerogen Pharma Limited
• ENROLLING BY INVITATIONNANCT07235345
  To Investigate the Effect of Pulmonary Surfactant With Different Inspired Oxygen Concentrations on the Clinical Outcomes of Very Preterm Infants Under Non-invasive Assisted Ventilation
  Xu Falin
• RECRUITINGNANCT06757543
  A Stepped Wedge Cluster Randomised Trial of Video Versus Direct Laryngoscopy for Intubation of Newborn Infants
  University College Dublin
• RECRUITINGNCT06758492
  A Prospective Observational Study of Video Laryngoscopy Versus Direct Laryngoscopy for Insertion of a Thin Endotracheal Catheter for Surfactant Administration in Newborn Infants
  University College Dublin
• RECRUITINGNANCT06622902
  Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants.
  Rambam Health Care Campus

See all trials for Infant acute respiratory distress syndrome →